Epidemiology of lung cancer: Looking to the future

被引:333
作者
Alberg, AJ
Brock, MV
Samet, JM
机构
[1] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Sch Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Surg, Sidney Kimmel Comprehens Canc Ctr,Sch Med, Baltimore, MD 21205 USA
关键词
D O I
10.1200/JCO.2005.10.462
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In the United States, the 20th century witnessed the emergence of a lung cancer epidemic that peaked and began to decline by the century's end, a decline that continues today, However, lung cancer continues to be an unabating pandemic. In research carried out over the last half of the 20th century, many factors were causally associated with lung cancer and studies were implemented to identify determinants of susceptibility to these factors. Cigarette smoking was identified as the single most predominant cause of the lung cancer epidemic, but other causes were found, including workplace agents leg, asbestos, arsenic, chromium, nickel, and radon) and other environmental factors (passive smoking, indoor radon, and air pollution). Contemporary epidemiologic research on lung cancer now focuses on a new set of issues, primarily related to susceptibility to the well-identified causal factors, particularly smoking, and on the consequences of changes in tobacco products for risks to smokers. Diet and the possibility of reducing risk through chemoprevention remain a focus of research emphasis through experimental and observational approaches. Questions have also been raised about possible differences in susceptibility to lung cancer by sex and race. Population patterns in smoking prevalence will continue to be the most powerful predictor of the future occurrence of lung cancer. Evaluation of recent US patterns in smoking prevalence indicates that for the next approximately 10 to 15 years, lung cancer rates will decrease, but will then level off starting in approximately 2030. Unless further reductions in the prevalence of cigarette smoking are achieved over the next decade, lung cancer will remain as an all too common, but avoidable, disease. (c) 2005 by American Society of Clinical Oncology.
引用
收藏
页码:3175 / 3185
页数:11
相关论文
共 130 条
  • [91] Race, socioeconomic status and stage at diagnosis for five common malignancies
    Schwartz, KL
    Crossley-May, H
    Vigneau, FD
    Brown, K
    Banerjee, M
    [J]. CANCER CAUSES & CONTROL, 2003, 14 (08) : 761 - 766
  • [92] SHAW GL, 1995, CANCER EPIDEM BIOMAR, V4, P41
  • [93] MENTHOLATED CIGARETTE USE AND LUNG-CANCER
    SIDNEY, S
    TEKAWA, IS
    FRIEDMAN, GD
    SADLER, MC
    TASHKIN, DP
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (07) : 727 - 732
  • [94] Does insufficient adjustment for smoking explain the preventive effects of fruit and vegetables on lung cancer?
    Skuladottir, H
    Tjoenneland, A
    Overvad, K
    Stripp, C
    Christensen, J
    Raaschou-Nielson, O
    Olsen, JH
    [J]. LUNG CANCER, 2004, 45 (01) : 1 - 10
  • [95] K-RAS ONCOGENE ACTIVATION AS A PROGNOSTIC MARKER IN ADENOCARCINOMA OF THE LUNG
    SLEBOS, RJC
    KIBBELAAR, RE
    DALESIO, O
    KOOISTRA, A
    STAM, J
    MEIJER, CJLM
    WAGENAAR, SS
    VANDERSCHUEREN, RGJRA
    VANZANDWIJK, N
    MOOI, WJ
    BOS, JL
    RODENHUIS, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (09) : 561 - 565
  • [96] RELATIONSHIP BETWEEN K-RAS ONCOGENE ACTIVATION AND SMOKING IN ADENOCARCINOMA OF THE HUMAN LUNG
    SLEBOS, RJC
    HRUBAN, RH
    DALESIO, O
    MOOI, WJ
    OFFERHAUS, GJA
    RODENHUIS, S
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (14) : 1024 - 1027
  • [97] The FHIT gene at 3p14.2 is abnormal in lung cancer
    Sozzi, G
    Veronese, ML
    Negrini, M
    Baffa, R
    Cotticelli, MG
    Inoue, H
    Tornielli, S
    Pilotti, S
    DeGregorio, L
    Pastorino, U
    Pierotti, MA
    Ohta, M
    Huebner, K
    Croce, CM
    [J]. CELL, 1996, 85 (01) : 17 - 26
  • [98] Spitz MR, 2000, CANCER EPIDEM BIOMAR, V9, P1017
  • [99] SPITZ MR, 1995, CANCER EPIDEM BIOMAR, V4, P99
  • [100] Spitz MR, 2003, CANCER EPIDEM BIOMAR, V12, P689